- Home
- PLRX vs SSYS Comparison
PLRX vs SSYS Comparison
Compare PLRX & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | SSYS |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.9M | 892.8M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PLRX | SSYS |
|---|---|---|
| Price | $1.31 | $7.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $2.67 | ★ $12.33 |
| AVG Volume (30 Days) | 597.2K | ★ 1.0M |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.69 |
| Revenue Next Year | N/A | $6.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $7.83 |
| 52 Week High | $1.95 | $12.78 |
Technical Indicators
Market Signals| Indicator | PLRX | SSYS |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 26.78 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.36 | $11.41 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 41.46 | 5.88 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.